Biotoxtech Financials
| 086040 Stock | KRW 5,440 50.00 0.91% |
Biotoxtech |
Understanding current and past Biotoxtech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biotoxtech's financial statements are interrelated, with each one affecting the others. For example, an increase in Biotoxtech's assets may result in an increase in income on the income statement.
The data published in Biotoxtech's official financial statements usually reflect Biotoxtech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biotoxtech. For example, before you start analyzing numbers published by Biotoxtech accountants, it's critical to develop an understanding of what Biotoxtech's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Biotoxtech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biotoxtech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biotoxtech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotoxtech Co. Please utilize our Beneish M Score to check the likelihood of Biotoxtech's management manipulating its earnings.
Biotoxtech Stock Summary
Biotoxtech competes with DIO, InBody CoLtd, and Soulbrain Holdings. Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea. Biotoxtech is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7086040003 |
| Business Address | 53 Yeongudanji ro |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.biotoxtech.com |
| Phone | (82) 43 210 7778 |
| Currency | KRW - South Korean Won |
You should never invest in Biotoxtech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Biotoxtech Stock, because this is throwing your money away. Analyzing the key information contained in Biotoxtech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Biotoxtech Key Financial Ratios
Generally speaking, Biotoxtech's financial ratios allow both analysts and investors to convert raw data from Biotoxtech's financial statements into concise, actionable information that can be used to evaluate the performance of Biotoxtech over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Biotoxtech reports annually and quarterly.| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Target Price | 15000.0 |
Biotoxtech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotoxtech's current stock value. Our valuation model uses many indicators to compare Biotoxtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotoxtech competition to find correlations between indicators driving Biotoxtech's intrinsic value. More Info.Biotoxtech Co is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . The ratio of Return On Equity to Return On Asset for Biotoxtech Co is about 386.80 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotoxtech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotoxtech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotoxtech's earnings, one of the primary drivers of an investment's value.Biotoxtech Systematic Risk
Biotoxtech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biotoxtech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Biotoxtech correlated with the market. If Beta is less than 0 Biotoxtech generally moves in the opposite direction as compared to the market. If Biotoxtech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biotoxtech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biotoxtech is generally in the same direction as the market. If Beta > 1 Biotoxtech moves generally in the same direction as, but more than the movement of the benchmark.
About Biotoxtech Financials
What exactly are Biotoxtech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Biotoxtech's income statement, its balance sheet, and the statement of cash flows. Potential Biotoxtech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biotoxtech investors may use each financial statement separately, they are all related. The changes in Biotoxtech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotoxtech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Biotoxtech Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Biotoxtech is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Biotoxtech has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Biotoxtech's financials are consistent with your investment objective using the following steps:- Review Biotoxtech's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Biotoxtech's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Biotoxtech's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Biotoxtech's stock is overvalued or undervalued.
Biotoxtech April 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biotoxtech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biotoxtech Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biotoxtech Co based on widely used predictive technical indicators. In general, we focus on analyzing Biotoxtech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biotoxtech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 18.87 | |||
| Value At Risk | (3.31) | |||
| Potential Upside | 2.7 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |